Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | SVP, Global Controller and CAO | August 11, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON SCIENTIFIC CORP
Report date August 11, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) | 2,930 |
Reported balance
After 2026-08-11 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-08-11 · Other · Acquired 2,930 · Balance 2,930 F1: Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock. |
| Common StockSEC Table I · non-derivative | Direct | 3,123 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,123 F2: Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.
F2: Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2026 Filed Aug 12, 2026 20:08 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | OtherCommon Stock | 2,930 | $51.19 | $149,986.70 |
DisclosureSEC source: 0001225208-26-007084 · doc4.xml · nonDerivative · entry 1 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Indirect · By 401(k) Disclosed balance after: 2,930 F1 · kind: Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:19 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 838 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-003014 · doc4.xml · derivative · entry 3 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,676 Underlying: Common Stock · 838 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:19 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 372 | $76.85 | $28,588.20 |
DisclosureSEC source: 0001225208-26-003014 · doc4.xml · nonDerivative · entry 2 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,859 Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:19 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 838 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-003014 · doc4.xml · nonDerivative · entry 1 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 637 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002139 · doc4.xml · derivative · entry 9 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 637 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 283 | $74.73 | $21,148.59 |
DisclosureSEC source: 0001225208-26-002139 · doc4.xml · nonDerivative · entry 6 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,393 Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 637 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002139 · doc4.xml · nonDerivative · entry 5 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 661 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002139 · doc4.xml · derivative · entry 8 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 661 Underlying: Common Stock · 661 shares Expires 2027-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F3 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. F3 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 296 | $74.73 | $22,120.08 |
DisclosureSEC source: 0001225208-26-002139 · doc4.xml · nonDerivative · entry 4 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,039 Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 661 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002139 · doc4.xml · nonDerivative · entry 3 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 1,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002139 · doc4.xml · derivative · entry 7 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,239 Underlying: Common Stock · 1,413 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 690 | $74.73 | $51,563.70 |
DisclosureSEC source: 0001225208-26-002139 · doc4.xml · nonDerivative · entry 2 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,674 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002139 · doc4.xml · nonDerivative · entry 1 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:07 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantStock Option (Right to Buy) · Derivative | 5,584 | $0.00 Strike: $74.12 | $0.00 |
DisclosureSEC source: 0001225208-26-002020 · doc4.xml · derivative · entry 5 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,584 Underlying: Common Stock · 5,584 shares Expires 2036-02-12 F5 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:07 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantRestricted Stock Units · Derivative | 6,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002020 · doc4.xml · derivative · entry 4 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,071 Underlying: Common Stock · 6,071 shares Expires 2030-02-12 F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:07 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 481 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002020 · doc4.xml · derivative · entry 3 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 962 Underlying: Common Stock · 481 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F3 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. F3 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:07 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 242 | $74.12 | $17,937.04 |
DisclosureSEC source: 0001225208-26-002020 · doc4.xml · nonDerivative · entry 2 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 951 Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:07 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 481 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002020 · doc4.xml · nonDerivative · entry 1 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · balance_after: Includes shares acquired on June 30, 2025 under the Company's Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 482 | $104.63 | $50,431.66 |
DisclosureSEC source: 0001225208-25-002992 · doc4.xml · nonDerivative · entry 3 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 432 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,949 | $0.00 Strike: $37.50 | $0.00 |
DisclosureSEC source: 0001225208-25-002992 · doc4.xml · derivative · entry 4 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,383 Underlying: Common Stock · 5,949 shares Expires 2031-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 7,149 | $104.97 | $750,464.85 |
DisclosureSEC source: 0001225208-25-002992 · doc4.xml · nonDerivative · entry 2 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 914 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.85 to $105.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 5,949 | $37.50 | $223,087.50 |
DisclosureSEC source: 0001225208-25-002992 · doc4.xml · nonDerivative · entry 1 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 21:11 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 837 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002655 · doc4.xml · derivative · entry 6 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,514 Underlying: Common Stock · 837 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 21:11 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 355 | $103.79 | $36,845.45 |
DisclosureSEC source: 0001225208-25-002655 · doc4.xml · nonDerivative · entry 4 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,114 Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 21:11 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 837 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002655 · doc4.xml · nonDerivative · entry 3 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:11 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,218 | $0.00 Strike: $42.16 | $0.00 |
DisclosureSEC source: 0001225208-25-002655 · doc4.xml · derivative · entry 5 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,218 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:11 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 9,887 | $101.13 | $999,872.31 |
DisclosureSEC source: 0001225208-25-002655 · doc4.xml · nonDerivative · entry 2 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,632 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:11 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 7,218 | $42.16 | $304,310.88 |
DisclosureSEC source: 0001225208-25-002655 · doc4.xml · nonDerivative · entry 1 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024. Read SEC document |
| February 17, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · derivative · entry 11 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 667 shares Expires 2025-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F6 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. F6 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. Read SEC document |
| February 17, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 283 | $106.11 | $30,029.13 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · nonDerivative · entry 6 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,301 Read SEC document |
| February 17, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · nonDerivative · entry 5 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 16, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 636 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · derivative · entry 10 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 637 Underlying: Common Stock · 636 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F5 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. F5 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. Read SEC document |
| February 16, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 271 | $106.11 | $28,755.81 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · nonDerivative · entry 4 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,917 Read SEC document |
| February 16, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 636 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · nonDerivative · entry 3 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 661 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · derivative · entry 9 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,322 Underlying: Common Stock · 661 shares Expires 2027-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 315 | $106.11 | $33,424.65 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · nonDerivative · entry 2 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,552 Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 661 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · nonDerivative · entry 1 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantStock Option (Right to Buy) · Derivative | 5,732 | $0.00 Strike: $106.14 | $0.00 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · derivative · entry 8 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,732 Underlying: Common Stock · 5,732 shares Expires 2035-02-13 F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 22:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantRestricted Stock Units · Derivative | 5,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001880 · doc4.xml · derivative · entry 7 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,652 Underlying: Common Stock · 5,652 shares Expires 2029-02-13 F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 480 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001796 · doc4.xml · derivative · entry 3 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,443 Underlying: Common Stock · 480 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 231 | $105.77 | $24,432.87 |
DisclosureSEC source: 0001225208-25-001796 · doc4.xml · nonDerivative · entry 2 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,206 Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 480 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001796 · doc4.xml · nonDerivative · entry 1 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:46 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 1,336 | $90.65 | $121,105.19 |
DisclosureSEC source: 0001225208-24-010326 · doc4.xml · nonDerivative · entry 1 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,957 F1 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $90.6202 to $90.6538, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes shares acquired on June 30, 2024 under the Company's Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:27 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantStock Option (Right to Buy) · Derivative | 3,421 | $0.00 Strike: $67.13 | $0.00 |
DisclosureSEC source: 0001225208-24-003608 · doc4.xml · derivative · entry 2 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,421 Underlying: Common Stock · 3,421 shares Expires 2034-03-01 F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:27 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantRestricted Stock Units · Derivative | 3,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003608 · doc4.xml · derivative · entry 1 Woodworth Emily · CIK 0002013518 · SVP, Global Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,351 Underlying: Common Stock · 3,351 shares Expires 2028-03-01 F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.